Stratasys TrueDent Resin Receives European CE Medical Device Certification
Stratasys Ltd. Announced today that its TrueDent® resins have received CE marking as a Class IIa medical device, a certification that positions the company as the first to offer a high-esthetic, monolithic 3D-printed denture solution approved for use in Europe’s more than $2 billion denture market. The certification, granted on March 17, 2026, expands the clinical applications of TrueDent resins to include long-term intraoral removables and crowns and bridges.
The CE Class IIa designation signifies that TrueDent resins have undergone rigorous independent third-party evaluation and meet heightened regulatory standards under the European Medical Device Regulation (MDR). This includes validation of biocompatibility, manufacturing controls, traceability protocols, and clinical performance, according to Stratasys.
“Achieving CE Class IIa certification for TrueDent is an critical milestone and supports the continued expansion of our dental business in Europe,” said Chris Kabot, Vice President Dental, Stratasys. “By aligning TrueDent with the regulatory classification customers grasp and expect, we are providing additional clarity and confidence for clinicians and laboratories as they expand digital denture and temporary restoration workflows across the region.”
Prior to this Class IIa certification, Stratasys’ TrueDent-D™ received CE Class I certification in early 2025 for denture production in Europe. The upgrade to Class IIa broadens the scope of approved applications, allowing for the 3D printing of removable partial frameworks and fixed crown and bridge restorations.
According to a 2024 iData report, the European denture market is projected to grow from $2.19 billion in 2023 to $2.45 billion by 2028. The certification is expected to support broader clinical adoption and strengthen the commercial foundation for growth within the region as European providers increasingly adopt digital denture production technologies.
The Class IIa designation requires independent third-party evaluation and rigorous oversight, a standard that builds confidence among laboratories and dental practitioners for routine clinical use. The new classification covers intraoral removable appliances for extended wear exceeding 30 days and permanent crown and bridge fabrication, allowing production facilities to manage diverse restorative requirements through a unified digital manufacturing pipeline.